Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management

Medical Mycology
Corrado GirmeniaFranco Aversa

Abstract

In the attempt to establish definitions and provide shared approaches to breakthrough invasive fungal diseases (br-IFD) in acute myeloid leukemia (AML) patients submitted to intensive chemotherapy and receiving triazoles as mould active primary antifungal prophylaxis (MA-PAP), literature on br-IFD in AML patients receiving triazoles MA-PAP was reviewed and a Consensus Development Conference Project was convened. The following four candidate key-questions were generated and formed the set of questions of the present document: "definition of br-IFD," "diagnostic strategy during MA-PAP to detect br-IFD," "possible causes of MA-PAP failure," "management of br-IFD."

References

Jan 1, 1994·Journal of Advanced Nursing·P L Williams, C Webb
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrWendy Leisenring
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Oct 21, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corrado GirmeniaPietro Martino
Dec 4, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gloria N MattiuzziHagop Kantarjian
Jul 28, 2010·Bone Marrow Transplantation·J MaertensUNKNOWN Third European Conference on Infections in Leukemia
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Dec 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta StanzaniNicola Vianelli
Mar 3, 2012·Haematologica·Johan A MaertensJ Peter Donnelly
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·Michael J DoltonAndrew J McLachlan
Sep 8, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Livio PaganoUNKNOWN SEIFEM Group
Dec 13, 2012·Annals of the New York Academy of Sciences·Sevtap Arikan-Akdagli
Mar 13, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O A CornelyA J Ullmann
Jun 21, 2014·The Journal of Antimicrobial Chemotherapy·Livio PaganoMario Tumbarello
Jun 26, 2014·Mycoses·Georg Maschmeyer, Thomas F Patterson
Aug 29, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rafael F DuarteManuel Cuenca-Estrella
Jan 31, 2015·American Journal of Respiratory and Critical Care Medicine·Petra BacherAlexander Scheffold
Feb 28, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta StanzaniGiuseppe Battista
Mar 25, 2015·Journal of Cancer Research and Clinical Oncology·Karin G SchrenkSebastian Scholl
May 20, 2015·Emerging Infectious Diseases·J W M van der LindenP E Verweij
Jun 27, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Lewis WhiteJ Peter Donnelly
Jul 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marios ArvanitisEleftherios Mylonakis
Aug 19, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Paul E VerweijJ Peter Donnelly
Jun 19, 2016·The Journal of Antimicrobial Chemotherapy·Lena M BiehlMaria J G T Vehreschild

❮ Previous
Next ❯

Citations

Jun 30, 2019·Mycoses·Oliver A CornelyUNKNOWN Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM)
May 1, 2021·Journal of Fungi·Carmine LiberatoreJacopo Peccatori
Dec 23, 2021·Internal Medicine Journal·Abby P DouglasUNKNOWN Australasian Antifungal Guidelines Steering Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.